期刊文献+

开滦集团社区心房颤动人群全因死亡及其相关因素的观察 被引量:1

Observation on all-cause death and related factors of atrial fibrillation in Kailuan Group Community
原文传递
导出
摘要 目的 探讨社区非瓣膜性心房颤动(简称房颤)患者全因、心脑血管死亡率及危险因素。方法 2006~2007年度对开滦(集团)有限责任公司在职和离退职工101 510例进行健康体检,对经12导联心电图检出的房颤患者作为观察对象。课题组专人每半年进行一次电话随访,每2年进行一次面对面随访。住院期间死亡者由经过培训的医务人员调取住院病历,根据ICD~10疾病编码确定死因。非住院死亡者与所在工作单位工会和(或)户口所在地的派出所核实。至2013年12月31日完成末次随访。采用Cox比例风险模型分析影响房颤患者全因、心脑血管死亡的危险因素。结果 (1)438例房颤患者,排除器质性心脏病和瓣膜性房颤48例,对390例房颤患者平均随访71.5个月,1例因服毒自杀。389例房颤患者累积全因、心脑血管死亡率为35.0%(年37.5‰)、20.6%(年18.7‰)。CHADS2评分分层分析,低、中、高危房颤患者累积全因死亡率分别为22.9%、30.2%、47.2%,心脑血管死亡率为4.8%、15.4%、35.4%,经Log-rank检验差异均达到统计学意义(P<0.01或P<0.05);(2)多因素Cox比例风险模型分析,年龄(HR:1.063,95%CI:1.042~1.085)、血尿酸(HR:1.003,95%CI:1.001~1.005)、心室率<80次/分(HR:1.784,95%CI:1.253~2.538)为房颤患者全因死亡的独立危险因素。年龄(HR:1.093,95%CI:1.062~1.126)、血尿酸(HR:1.004,95%CI:1.002~1.006)、心力衰竭(HR:2.031,95%CI:1.137~3.628)为房颤患者心脑血管死亡的独立危险因素;(3)以CHADS2评分分层建立Cox比例风险模型,以低危为参照,高危患者全因、心血管死亡风险比分别为2.495(95%CI:1.461~4.262)、7.661(95%CI:2.710~21.656)。结论 (1)年龄、血尿酸、心室率<80次/分是房颤患者全因死亡的独立危险因素。年龄、血尿酸及心力衰竭是房颤患者心脑血管死亡的独立危险因素;(2)CHADS2评分分层能预测房颤患者全因、心脑血管死亡。 Objective To investigate the all-cause, cardiovascular and cerebrovascular mortality and risk factors of patients with non-valvular atrial fibrillation including atrial flutter in community. Methods From 2006 to 2007, 101510 in-service and retired employees of Kailuan(Group) Co., Ltd. underwent physical examination. Patients with atrial fibrillation detected by 12 lead ECG were observed. The special personnel of the research group conduct telephone follow-up every six months and face-to-face follow-up every two years. For those who died during hospitalization, the trained medical personnel shall obtain the inpatient medical records and determine the cause of death according to the ICD-10 disease code. The non hospitalized death shall be verified with the labor union of the work unit and/or the local police station where the registered permanent residence was located. The last follow-up was completed on December 31, 2013. Cox proportional hazards model was used to analyze the risk factors of all-cause and cardiovascular and cerebrovascular death in patients with atrial fibrillation. Results(1) Among 438patients with atrial fibrillation,48patients with organic heart disease and valvular atrial fibrillation were excluded.390patients with atrial fibrillation were followed up for an average of 71.5months,and 1patient committed suicide due to taking poison. The cumulative all-cause,cardio cerebrovascular mortality of 389patients with atrial fibrillation was 35.0%(37.5‰ person years)and 20.6%(18.7‰ person years).According to the stratified analysis of CHADS2score,the cumulative all-cause mortality of low,medium and high-risk patients with atrial fibrillation were 22.9%,30.2%and 47.2%respectively,and the cardiovascular and cerebrovascular mortality were 4.8%,15.4%and 35.4%respectively.The difference was statistically significant by log rank test(P<0.01or P< 0.05);(2) Multivariate Cox proportional hazards model analysis showed that age(HR:1.063,95%CI:1.042-1.085),blood uric acid(HR:1.003,95%CI:1.001-1.005)and ventricular rate< 80beats/minute(HR:1.784,95%CI:1.253-2.538)were independent risk factors for all-cause death in patients with atrial fibrillation.Age(HR:1.093,95%CI:1.062-1.126),blood uric acid(HR:1.004,95%CI:1.002-1.006),heart failure(HR:2.031,95%CI:1.137-3.628)were independent risk factors for cardiovascular and cerebrovascular death in patients with atrial fibrillation;(3) The Cox proportional hazards model was established according to the CHADS2score.Taking the low risk as the reference,the risk ratios of all-cause and cardiovascular death in high-risk patients were 2.495(95%CI:1.461-4.262)and 7.661(95%CI:2.710-21.656)respectively. Conclusion(1) age,serum uric acid and ventricular rate< 80beats/min are independent risk factors for all-cause death in patients with atrial fibrillation.Age,serum uric acid and heart failure were independent risk factors for cardiovascular and cerebrovascular death in patients with atrial fibrillation;(2) CHADS2score stratification can predict all-cause,cardiovascular and cerebrovascular death in patients with atrial fibrillation.
作者 邢爱君 王艳秀 刘学伟 董申 许继波 刘英 孙玉艳 吴云涛 赵海燕 吴寿岭 XING Ai-jun;WANG Yan-xiu;LIU Xue-wei;DONG Shen;XU Ji-bo;LIU Ying;SUN Yu-yan;WU Yun-tao;ZHAO Hai-yan;WU Shou-ling(Department of Cardiology,Kailuan General Hospital,Tangshan 063000,Hebei,China;Medical Department,Kailuan General Hospital,Tangshan 063000,Hebei,China;Tangjiazhuang Hospital of Kailuan Medical Group,Tangshan 063000,Hebei,China)
出处 《中国心脏起搏与心电生理杂志》 2022年第6期509-515,共7页 Chinese Journal of Cardiac Pacing and Electrophysiology
基金 河北省医学科学研究课题计划(20210929)。
关键词 心血管病学 心房颤动 全因死亡 心脑血管死亡 危险因素 社区 Cardiology Atrial fibrillation All cause death Cardiovascular and cerebrovascular death Risk factors Community
  • 相关文献

参考文献6

二级参考文献95

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2周英.高尿酸血症与高血压的关系初探[J].广西医学,2005,27(3):353-354. 被引量:29
  • 3徐伟民,毛旭东,曾文琴,席蓓莉,陆慧华.老年人群代谢综合征调查分析[J].实用临床医学(江西),2006,7(4):135-137. 被引量:4
  • 4陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12.
  • 5De'Marco M, De Simone G,Roman MJ, et al. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study[J]. Hypertension, 2009,54 (5) : 974-980.
  • 6Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperuricemia and incidence of hypertension among men without metabolic syndrome[J].Hypertehsion, 2007,49 (2) : 298-103.
  • 7Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study[J]. Hypertension,2000,36(6) :1072- 1078.
  • 8Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure[J].Hypertension, 2003,42(6) : 1206-1252.
  • 9Perlstein TS, Gumieniak O, Hopkins PN, et al. Uric acid and the state of the intrarenal renin-angiotensin system in human[J]. Kidney Int,2004,66(4) :1465-1470.
  • 10Sundstrom J, Sullivan L, D'Agostino RB, et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence[J]. Hypertension, 2005,45 (1) : 28-33.

共引文献5275

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部